Name: Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve
Brand: theprint.in
SKU: theprint-in-96
Availability: OnlineOnly

critic

Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve

preview

Sign inLog into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailSign inWelcome! Log into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailA password will be e-mailed to you.Text Size:A-A+New Delhi:Also Read:Also Read:an important aspectAEFI national committees (panels formed by different countries to monitor AEFI)Also Read:&nbsp;Subscribe to our channels on &amp;Why news media is in crisis &amp; How you can fix itIndia needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it .No doubt it is the prerogative of the country to give any kind of authorisation to any drug but the regulators and the company had been shouting from the roof tops that all protocols will be strictly followed and then clinical mode authorisation was given. If the regulators and the Govt were pro active, Phase 3 trials could have been started by Oct ’20, all inoculations completed by Nov ’20 and preliminary results got by end Jan – mid Feb and no questions would have been raised.Per the article, WHO representative said: “(Countries) have the autonomy to issue emergency-use authorisations for any health product.” Compare this to the paraphrasing in the title, “(India) has every right to”. Clickbaiting or bias?The headline of the article and the contents do not match. What Ms Singh seems to be suggesting is barely that India’s legislation allows approval which we know because we already did it. There seem to be no statements backing the vaccine and it’s efficacy. Wonder if we are starting to move towards sensational headlines ourselves.NEXT STORYSubstance of Print, Reach of DigitalContact us:Copyright © 2020 Printline Media Pvt. Ltd. All rights reserved.

Sign inLog into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailSign inWelcome! Log into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailA password will be e-mailed to you.Text Size:A-A+New Delhi:Also Read:Also Read:an important aspectAEFI national committees (panels formed by different countries to monitor AEFI)Also Read:&nbsp;Subscribe to our channels on &amp;Why news media is in crisis &amp; How you can fix itIndia needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple...

public

Himani Chandna

theprint.in

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS